524403 Sigma-AldrichPravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem
A water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM).
More>> A water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM). Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na, 3β-Hydroxycompactin, Na
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 81131-70-6 | C₂₃H₃₅O₇.Na |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 524403-25MGCN | Plastic Bag(s) | 25 mg |
| Product Information | |
|---|---|
| CAS number | 81131-70-6 |
| ATP Competitive | N |
| Form | White crystalline solid |
| Hill Formula | C₂₃H₃₅O₇.Na |
| Chemical formula | C₂₃H₃₅O₇.Na |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | QJ7185000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 524403-25MGCN | 04055977270983 |
Documentation
Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem MSDS
| 职位 |
|---|
Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 524403 |
参考
| 参考信息概述 |
|---|
| Kwak, B., et al. 2000. Natl. Med. 6, 1399. Hamelin, B.A., and Turgeon, J., 1998. Trends Pharmacol. Sci. 19, 26. Narisawa, T., et al. 1996. Jpn. J. Cancer Res. 87, 798. Cohen, L.H., et al. 1993. Biochem. Pharmacol. 45, 2203. Koga, T., et al. 1990. Biochim. Biophys. Acta. 1045, 115. Yoshino, G., et al. 1986. Diabetes Res. Clin. Pract. 2, 179 |